Law360, New York (July 27, 2009) -- The judge in charge of the multidistrict litigation over Wyeth Pharmaceuticals Inc.'s drug Prempro has unsealed discovery pertaining to "medical ghostwriting," granting a bid from a medical journal seeking to expose drugmakers that pay for journal articles.
On Friday, Judge William R. Wilson of the U.S. District Court for the Eastern District of Arkansas ordered that materials related to “ghostwriting” be de-designated as confidential as of June...
